Cargando…
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880761/ https://www.ncbi.nlm.nih.gov/pubmed/35215453 http://dx.doi.org/10.3390/nu14040805 |
_version_ | 1784659300889657344 |
---|---|
author | Ebrahim, Zarina Proost, Sebastian Tito, Raul Yhossef Raes, Jeroen Glorieux, Griet Moosa, Mohammed Rafique Blaauw, Renée |
author_facet | Ebrahim, Zarina Proost, Sebastian Tito, Raul Yhossef Raes, Jeroen Glorieux, Griet Moosa, Mohammed Rafique Blaauw, Renée |
author_sort | Ebrahim, Zarina |
collection | PubMed |
description | There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney function, uremic toxins and the gut microbiome in stage 3 to 5 CKD participants. Fifty-nine participants were randomized to either the ß-glucan prebiotic intervention group (n = 30) or the control group (n = 29). The primary outcomes were to assess kidney function (urea, creatinine and glomerular filtration rate), plasma levels of total and free levels of uremic toxins (p-cresyl sulfate (pCS), indoxyl-sulfate (IxS), p-cresyl glucuronide (pCG) and indoxyl 3-acetic acid (IAA) and gut microbiota using 16S rRNA sequencing at baseline, week 8 and week 14. The intervention group (age 40.6 ± 11.4 y) and the control group (age 41.3 ± 12.0 y) did not differ in age or any other socio-demographic variables at baseline. There were no significant changes in kidney function over 14 weeks. There was a significant reduction in uremic toxin levels at different time points, in free IxS at 8 weeks (p = 0.003) and 14 weeks (p < 0.001), free pCS (p = 0.006) at 14 weeks and total and free pCG (p < 0.001, p < 0.001, respectively) and at 14 weeks. There were no differences in relative abundances of genera between groups. Enterotyping revealed that the population consisted of only two of the four enterotypes: Bacteroides 2 and Prevotella. The redundancy analysis showed a few factors significantly affected the gut microbiome: these included triglyceride levels (p < 0.001), body mass index (p = 0.002), high- density lipoprotein (p < 0.001) and the prebiotic intervention (p = 0.002). The ß-glucan prebiotic significantly altered uremic toxin levels of intestinal origin and favorably affected the gut microbiome. |
format | Online Article Text |
id | pubmed-8880761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88807612022-02-26 The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial Ebrahim, Zarina Proost, Sebastian Tito, Raul Yhossef Raes, Jeroen Glorieux, Griet Moosa, Mohammed Rafique Blaauw, Renée Nutrients Article There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney function, uremic toxins and the gut microbiome in stage 3 to 5 CKD participants. Fifty-nine participants were randomized to either the ß-glucan prebiotic intervention group (n = 30) or the control group (n = 29). The primary outcomes were to assess kidney function (urea, creatinine and glomerular filtration rate), plasma levels of total and free levels of uremic toxins (p-cresyl sulfate (pCS), indoxyl-sulfate (IxS), p-cresyl glucuronide (pCG) and indoxyl 3-acetic acid (IAA) and gut microbiota using 16S rRNA sequencing at baseline, week 8 and week 14. The intervention group (age 40.6 ± 11.4 y) and the control group (age 41.3 ± 12.0 y) did not differ in age or any other socio-demographic variables at baseline. There were no significant changes in kidney function over 14 weeks. There was a significant reduction in uremic toxin levels at different time points, in free IxS at 8 weeks (p = 0.003) and 14 weeks (p < 0.001), free pCS (p = 0.006) at 14 weeks and total and free pCG (p < 0.001, p < 0.001, respectively) and at 14 weeks. There were no differences in relative abundances of genera between groups. Enterotyping revealed that the population consisted of only two of the four enterotypes: Bacteroides 2 and Prevotella. The redundancy analysis showed a few factors significantly affected the gut microbiome: these included triglyceride levels (p < 0.001), body mass index (p = 0.002), high- density lipoprotein (p < 0.001) and the prebiotic intervention (p = 0.002). The ß-glucan prebiotic significantly altered uremic toxin levels of intestinal origin and favorably affected the gut microbiome. MDPI 2022-02-14 /pmc/articles/PMC8880761/ /pubmed/35215453 http://dx.doi.org/10.3390/nu14040805 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ebrahim, Zarina Proost, Sebastian Tito, Raul Yhossef Raes, Jeroen Glorieux, Griet Moosa, Mohammed Rafique Blaauw, Renée The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title | The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title_full | The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title_fullStr | The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title_full_unstemmed | The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title_short | The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial |
title_sort | effect of ß-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (ckd) predialysis participants: a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880761/ https://www.ncbi.nlm.nih.gov/pubmed/35215453 http://dx.doi.org/10.3390/nu14040805 |
work_keys_str_mv | AT ebrahimzarina theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT proostsebastian theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT titoraulyhossef theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT raesjeroen theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT glorieuxgriet theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT moosamohammedrafique theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT blaauwrenee theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT ebrahimzarina effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT proostsebastian effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT titoraulyhossef effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT raesjeroen effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT glorieuxgriet effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT moosamohammedrafique effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial AT blaauwrenee effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial |